[Charles L. Schmidt]Mantle Cell Lymphoma : Clinical Characteristics, Prevalence and Treatment Options(pdf){Zzzzz} [BЯ]

[/center

Mantle cell lymphoma (MCL) is a subtype of Non-Hodgkin’s Lymphoma (NHL) with varying clinical presentations, ranging from indolent disease to highly aggressive symptoms. MCL represents approximately 3-10% of non-Hodgkin lymphomas, and has increased in incidence over the past several decades. The majority of patients respond to initial therapy, but remission duration is typically short. This book discusses the clinical characteristics of mantle cell lymphoma, as well as it's prevalence and examines several treatment options available. (Imprint: Nova Biomedical)

Table of Contents:
Preface

Diagnosis, Prognosis and Genetic Features of Mantle Cell Lymphoma
(Haipeng Shao, Department of Hematopathology and Laboratory Medicine
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA)

Mantle Cell Lymphoma: Current Treatment Strategies in the Era of Targeted Agents
(Muhammad Omer Jamil, Maira Rizwan, Amitkumar Mehta, Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA, and other)

Targeted Drugs in the Treatment of Mantle Cell Lymphoma
(Piotr Smolewski, Magdalena Witkowska, Tadeusz Robak, Department of Experimental Hematology, and Department of Hematology, Medical University of Lodz, Poland)

Emerging Role of Novel Agents in the Treatment of Mantle Cell Lymphoma
(Bridgette A. Kanz, Mahsa S. Talbott, Nishitha M. Reddy, Department of Pharmacology, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA)

Current Place of Proteasome Inhibitors in the Treatment of Mantle Cell Lymphoma
(Panagiotis J. Vlachostergios, Rajeev L. Balmiki, Department of Internal Medicine, Lutheran Medical Center, Brooklyn, NY, USA, and other)

Publisher: Nova Science Publishers Inc (1 June 2015)
Language: English
ISBN-10: 163482363X
ISBN-13: 978-1634823630